MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ImmunoGen Company Profile (NASDAQ:IMGN)

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 7 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.36)
Consensus Price Target: $14.15 (14.91% downside)

Analysts' Ratings History for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetActions
8/3/2015Cantor FitzgeraldDowngradeBuy -> Hold$22.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015OppenheimerBoost Price TargetOutperform$13.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015RBC CapitalReiterated RatingOutperform$15.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2015Leerink SwannBoost Price TargetMarket Perform$9.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015RBC CapitalReiterated RatingOutperform$10.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Cantor FitzgeraldReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015OppenheimerReiterated RatingOutperform$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Morgan StanleyUpgradeUnderweight -> Equal Weight$5.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Canaccord GenuityBoost Price TargetBuy$15.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Canaccord GenuityReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Credit SuisseInitiated CoverageNeutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Canaccord GenuityReiterated RatingBuy$10.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2015Cantor FitzgeraldReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Cantor FitzgeraldUpgradeHold -> Buy$9.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015OppenheimerUpgradeMarket Perform -> Outperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014JPMorgan Chase & Co.Reiterated RatingHold$13.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014Cantor FitzgeraldDowngradeHold$14.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014RBC CapitalLower Price TargetOutperform$18.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Jefferies GroupDowngradeBuy -> Hold$20.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Cowen and CompanyInitiated CoverageMarket Perform$8.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Morgan StanleyInitiated CoverageUnderweight$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2014Canaccord GenuityInitiated CoverageBuy -> Buy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2014GuggenheimBoost Price Target$14.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013Morgan StanleyDowngradeEqual Weight -> Underweight$9.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2013RBC CapitalLower Price TargetOutperform$22.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013Chardan CapitalReiterated RatingBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013GuggenheimLower Price TargetNeutral$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2013Stifel NicolausDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2013Chardan CapitalInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2013Jefferies GroupReiterated RatingPositive -> Buy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2013Leerink SwannInitiated CoverageOutperform$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2013Roth CapitalInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2013Credit SuisseBoost Price TargetNeutral$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2013RBC CapitalBoost Price TargetOutperform$17.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2013GuggenheimBoost Price TargetNeutral$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2013Cantor FitzgeraldBoost Price TargetHold$13.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha